Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial
- PMID: 15741528
- DOI: 10.1001/jama.293.9.1063
Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial
Abstract
Context: Atheromatous and thrombotic embolization during percutaneous coronary intervention (PCI) in acute myocardial infarction is common and may result in microcirculatory dysfunction, the prevention of which may improve reperfusion success, reduce infarct size, and enhance event-free survival.
Objective: To determine whether protection of the distal microcirculation from thromboembolic debris liberated during primary PCI results in improved reperfusion and decreased infarct size.
Design, setting, and patients: Prospective randomized controlled trial at 38 academic and community-based institutions in 7 countries enrolling 501 patients aged 18 years or older with ST-segment elevation myocardial infarction (STEMI) presenting within 6 hours of symptom onset and undergoing primary PCI or rescue intervention after failed thrombolysis.
Interventions: Patients were randomized between May 20, 2002, and November 21, 2003, to receive PCI with a balloon occlusion and aspiration distal microcirculatory protection system vs angioplasty without distal protection.
Main outcome measures: Coprimary end points were ST-segment resolution (STR) measured 30 minutes after PCI by continuous Holter monitoring and infarct size measured by technetium Tc 99m sestamibi imaging between days 5 and 14. Secondary end points included major adverse cardiac events.
Results: Among 252 patients assigned to distal protection, aspiration was performed in 97% (242/251), all angioplasty balloon inflations were fully protected in 79% (193/245), and visible debris was retrieved from 73% (182/250). Complete STR was achieved in a similar proportion reperfused with vs without distal protection (63.3% [152/240] vs 61.9% [148/239], respectively; absolute difference, 1.4% [95% confidence interval, -7.7% to 10.5%; P = .78]), and left ventricular infarct size was similar in both groups (median, 12.0% [n = 229] vs 9.5% [n = 208], respectively; P = .15). Major adverse cardiac events at 6 months occurred with similar frequency in the distal protection and control groups (10.0% vs 11.0%, respectively; P = .66).
Conclusions: A distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute STEMI undergoing emergent PCI. Nonetheless, distal embolic protection did not result in improved microvascular flow, greater reperfusion success, reduced infarct size, or enhanced event-free survival.
Comment in
-
Distal embolic protection in patients with acute myocardial infarction: attractive concept but no evidence of benefit.JAMA. 2005 Mar 2;293(9):1116-8. doi: 10.1001/jama.293.9.1116. JAMA. 2005. PMID: 15741535 No abstract available.
Similar articles
-
Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study.JACC Cardiovasc Interv. 2009 Oct;2(10):934-43. doi: 10.1016/j.jcin.2009.07.013. JACC Cardiovasc Interv. 2009. PMID: 19850252 Clinical Trial.
-
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).Am J Cardiol. 2007 Jul 15;100(2):206-10. doi: 10.1016/j.amjcard.2007.02.080. Epub 2007 Jun 4. Am J Cardiol. 2007. PMID: 17631071 Clinical Trial.
-
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR).Am J Cardiol. 2007 Feb 1;99(3):357-63. doi: 10.1016/j.amjcard.2006.08.038. Epub 2006 Dec 13. Am J Cardiol. 2007. PMID: 17261398 Clinical Trial.
-
Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.Eur Heart J. 2017 Jun 1;38(21):1656-1663. doi: 10.1093/eurheartj/ehx159. Eur Heart J. 2017. PMID: 28407050 Review.
-
Epicardial and microvascular reperfusion with primary percutaneous coronary intervention.Ital Heart J. 2005 Jun;6(6):447-52. Ital Heart J. 2005. PMID: 16008148 Review.
Cited by
-
Recent advances in primary percutaneous intervention for acute myocardial infarction.Heart. 2005 Dec;91(12):1533-6. doi: 10.1136/hrt.2005.064493. Heart. 2005. PMID: 16287736 Free PMC article. Review. No abstract available.
-
Periprocedural myocardial infarction: review and classification.Clin Cardiol. 2010 Aug;33(8):476-83. doi: 10.1002/clc.20819. Clin Cardiol. 2010. PMID: 20734444 Free PMC article. Review.
-
Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.J Thromb Thrombolysis. 2010 Jul;30(1):23-8. doi: 10.1007/s11239-009-0419-y. J Thromb Thrombolysis. 2010. PMID: 19921103
-
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.Cardiovasc Interv Ther. 2018 Apr;33(2):178-203. doi: 10.1007/s12928-018-0516-y. Epub 2018 Mar 29. Cardiovasc Interv Ther. 2018. PMID: 29594964 Free PMC article.
-
Treating acute "no-reflow" with intracoronary adenosine in 4 patients during percutaneous coronary intervention.Tex Heart Inst J. 2008;35(4):439-46. Tex Heart Inst J. 2008. PMID: 19156238 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous